{"nctId":"NCT00887250","briefTitle":"A Study to Investigate the Antihypertensive Efficacy of MK0954","startDateStruct":{"date":"1991-12"},"conditions":["Hypertension"],"count":366,"armGroups":[{"label":"1","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Comparator: Placebo"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: losartan potassium"]},{"label":"3","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: losartan"]}],"interventions":[{"name":"losartan potassium","otherNames":["MK0954"]},{"name":"Comparator: losartan","otherNames":["MK0954"]},{"name":"Comparator: Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient has been diagnosed with mild to moderate hypertension (SDBP 95-115 mm Hg)\n* Patient has no medical problems or treatments that might effect their blood pressure\n\nExclusion Criteria:\n\n* Pregnant or lactating females\n* Patient has secondary hypertension or malignant hypertension\n* Sitting systolic blood pressure \\> 210 mm Hg\n* History of stroke\n* History of myocardial infarction with in past year\n* Current or prior history of heart failure\n* Known hypersensitivity to losartan\n* Prior exposure to losartan\n* Patients known to be HIV positive\n* Patient is abusing or has abused alcohol or other drugs within the past 4 years","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change From Baseline in Trough Sitting Diastolic Blood Pressure (SiDBP) at Week 12","description":"Mean change from baseline in trough (24 hours post dose) SiDBP at Week 12","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.3","spread":"6.7"},{"groupId":"OG001","value":"-7.9","spread":"7.6"},{"groupId":"OG002","value":"-8.6","spread":"7.7"}]}]}]},{"type":"SECONDARY","title":"Categories of Hypertensive Response in Trough Diastolic Blood Pressure (SiDBP) at Week 6","description":"Patients with trough SiDBP \\<90 mm Hg were in Category I, ≥90 but decreased at least 10 mm Hg were in Category II, and ≥90 and decreased less than 10 mm Hg were in Category III.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"20","spread":null},{"groupId":"OG002","value":"21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null},{"groupId":"OG001","value":"68","spread":null},{"groupId":"OG002","value":"60","spread":null}]}]}]},{"type":"SECONDARY","title":"Categories of Hypertensive Response in Trough Diastolic Blood Pressure (SiDBP) at Week 12","description":"Patients with trough SiDBP \\<90 mm Hg were in Category I, ≥90 but decreased at least 10 mm Hg were in Category II, and ≥90 and decreased less than 10 mm Hg were in Category III.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"40","spread":null},{"groupId":"OG002","value":"37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"18","spread":null},{"groupId":"OG002","value":"24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"83","spread":null},{"groupId":"OG001","value":"67","spread":null},{"groupId":"OG002","value":"57","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Trough Sitting Diastolic Blood Pressure (SiDBP) at Week 6","description":"Mean change from baseline in trough (24 hours post dose) SiDBP at Week 6","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.5","spread":"5.8"},{"groupId":"OG001","value":"-6.9","spread":"7.0"},{"groupId":"OG002","value":"-7.9","spread":"7.1"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Peak Sitting Diastolic Blood Pressure (SiDBP) at Week 6","description":"Mean change from baseline in peak (6 hours post dose) SiDBP at Week 6","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.1","spread":"6.9"},{"groupId":"OG001","value":"-9.7","spread":"8.7"},{"groupId":"OG002","value":"-8.9","spread":"8.7"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Peak Sitting Diastolic Blood Pressure (SiDBP) at Week 12","description":"Mean change from baseline in peak (6 hours post dose) SiDBP at Week 12","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.7","spread":"7.9"},{"groupId":"OG001","value":"-9.5","spread":"9.2"},{"groupId":"OG002","value":"-10.1","spread":"8.6"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":null,"commonTop":[]}}}